Volker Koscielny - Almirall Chief Medical Officer
| ALM Stock | EUR 8.34 0.02 0.24% |
Insider
Volker Koscielny is Chief Medical Officer of Almirall SA since 2019.
| Tenure | 5 years |
| Phone | 34 93 291 30 00 |
| Web | https://www.almirall.com |
Almirall Management Efficiency
The company has return on total asset (ROA) of 0.0204 % which means that it generated a profit of $0.0204 on every $100 spent on assets. This is way below average. Almirall's management efficiency ratios could be used to measure how well Almirall manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jesus Barandiaran | CIE Automotive SA | 56 | |
| Mercedes Snchez | Laboratorios Farmaceuticos ROVI | N/A | |
| Amaia Telleria | ENCE Energa y | N/A | |
| Beatriz Alcalde | Laboratorios Farmaceuticos ROVI | N/A | |
| M Perez | Laboratorios Farmaceuticos ROVI | N/A | |
| Jos Garca | Acerinox | N/A | |
| M Tubau | Grifols SA | N/A | |
| Marc Ferret | ENCE Energa y | N/A | |
| Faustino Rodriguez | ENCE Energa y | N/A | |
| Nuria Lapea | Grifols SA | 59 | |
| Raimon Roura | Grifols SA | 59 | |
| Susana Apellaniz | CIE Automotive SA | 53 | |
| Ignacio Toledano | Laboratorios Farmaceuticos ROVI | N/A | |
| Mikel Landn | CIE Automotive SA | 61 | |
| Fernando Gutierrez | Acerinox | N/A | |
| Montserrat Llamas | Grifols SA | 58 | |
| Oswald Gmez | Acerinox | 63 | |
| Aitor Goni | CIE Automotive SA | 53 | |
| Alfredo Pea | ENCE Energa y | 56 | |
| Marcos Pinto | Laboratorios Farmaceuticos ROVI | N/A | |
| Vctor Deu | Grifols SA | 46 | |
Management Performance
| Return On Equity | 0.0071 | |||
| Return On Asset | 0.0204 |
Almirall SA Leadership Team
Elected by the shareholders, the Almirall's board of directors comprises two types of representatives: Almirall inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Almirall. The board's role is to monitor Almirall's management team and ensure that shareholders' interests are well served. Almirall's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Almirall's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Independent Director | ||
| Antonio Torrededia, Director | ||
| Francesca Wuttke, Chief Digital Officer | ||
| Esteve Conesa, Senior Vice President of Human Resources | ||
| Karl Ziegelbauer, CSO RD | ||
| Gerhard Mayr, Independent Director | ||
| Eloi Cervera, Vice President - Manufacturing & Technical Services | ||
| Pablo Alvarez, President and GM - US | ||
| Peter Guenter, Chief Executive Officer, Executive Director | ||
| Enrique Perez, Independent Director | ||
| Esteve Panicot, VP Board | ||
| Carlos Piqu, Interim Board | ||
| Bhushan Hardas, Chief Scientific Officer y Executive Vice President Research and Development | ||
| Michael McClellan, Chief Financial Officer, Executive Vice President - Finance | ||
| Thomas McKillop, Independent Vice Chairman of the Board | ||
| Karin Dorrepaal, Independent Director | ||
| Jordi Richer, Senior Vice President - Corporate Development | ||
| Amita Kent, Senior Vice President Legal, Global Chief Compliance & Data Privacy Officer | ||
| Jose Sala, Non-Member Secretary of the Board | ||
| Alfredo Juan, Executive Vice President - Global Commercial Operations | ||
| Paolo Cionini, Chief Board | ||
| Carlos Pique, Director | ||
| Jorge Ballart, Chairman of the Board | ||
| Volker Koscielny, Chief Medical Officer | ||
| Seth Orlow, Independent Director | ||
| Joan Carreras, Vice Secretary (non-member) General Counsel |
Almirall Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Almirall a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0071 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.82 B | |||
| Shares Outstanding | 181.43 M | |||
| Shares Owned By Insiders | 59.60 % | |||
| Shares Owned By Institutions | 16.58 % | |||
| Price To Earning | 40.31 X | |||
| Price To Book | 1.22 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Almirall Stock
Almirall financial ratios help investors to determine whether Almirall Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Almirall with respect to the benefits of owning Almirall security.